Island Pharmaceuticals Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Island Pharmaceuticals's earnings have been declining at an average annual rate of -17.2%, while the Pharmaceuticals industry saw earnings growing at 35.4% annually. Revenues have been growing at an average rate of 137.8% per year.
Belangrijke informatie
-17.2%
Groei van de winst
28.9%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 31.2% |
| Inkomstengroei | 137.8% |
| Rendement op eigen vermogen | -188.6% |
| Nettomarge | -228.9% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Island Pharmaceuticals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -3 | 2 | 0 |
| 31 Mar 24 | 1 | -3 | 2 | 0 |
| 31 Dec 23 | 1 | -2 | 2 | 1 |
| 30 Sep 23 | 0 | -3 | 2 | 1 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -3 | 2 | 0 |
| 31 Dec 22 | 0 | -3 | 2 | 1 |
| 30 Sep 22 | 0 | -3 | 2 | 1 |
| 30 Jun 22 | 0 | -3 | 2 | 1 |
| 31 Mar 22 | 0 | -3 | 2 | 1 |
| 31 Dec 21 | 0 | -3 | 3 | 0 |
| 30 Sep 21 | 0 | -3 | 2 | 0 |
| 30 Jun 21 | 0 | -2 | 2 | 0 |
| 30 Jun 20 | 0 | 0 | 0 | 0 |
| 31 Dec 19 | 0 | -1 | 0 | 1 |
Kwaliteitswinsten: ILA is currently unprofitable.
Groeiende winstmarge: ILA is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ILA is unprofitable, and losses have increased over the past 5 years at a rate of 17.2% per year.
Versnelling van de groei: Unable to compare ILA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ILA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (46.5%).
Rendement op eigen vermogen
Hoge ROE: ILA has a negative Return on Equity (-188.59%), as it is currently unprofitable.